Controlling TCR and CAR activation by targeting LCK recruitment with a first-in-class small-molecule inhibitor
Nadine M. Woessner, Patricio Chinestrad, Tamina Rückert, Lena Weiß, Marina Zintchenko, Anna-Maria Schaffer, Sara E. Hartmann, Azin Kiani, Maja Köhn, Cabrera Maia, Frederike A. Hartl, Wolfgang W A Schamel, Natalie Köhler, Pablo Lorenzano Menna, Susana Minguet
This study identifies a small-molecule inhibitor that selectively disrupts LCK recruitment to CD3ε, reducing TCR activation while preserving other immune responses.
bioRxiv · Dec 12, 2025 · PreprintImmunology